Drug peptide
CAS No.:
320367-13-3
Molecular formula:
C215H347N61O65S
Molecular Weight:
4858.53
Amino acids sequence:
H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2
Application:
Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. Therapy with lixisenatide has not been associated with serum enzyme elevations or with episodes of clinically apparent liver injury.
Notes: For research use only
全國(guó)統(tǒng)一服務(wù)熱線:025-58861700
© Copyright 南京杰肽生物科技有限公司 All Rights Reserved備案號(hào):蘇ICP備17002499號(hào)-1